Oral Small-Molecule Elecoglipron Tackles Obesity and Diabetes

(MedPage Today) -- NEW ORLEANS--Treatment with investigational elecoglipron led to weight loss in people with obesity and improved glucose control in those with type 2 diabetes, a pair of global phase II randomized trials showed.
In the dose...